Ensayo clínico

RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures

NCT: NCT04796350 · RECRUITING

ID NCTNCT04796350

EstadoRECRUITING

Fecha de inicio2021-04-24

Finalización2029-04-01

SponsorAgNovos Healthcare, LLC (INDUSTRY)

First posted2021-03-12

Last updated2026-05-13

Resumen breve

A randomized controlled trial to evaluate AGN1 to prevent secondary hip fractures in osteoporotic women undergoing treatment of index hip fractures. Up to 2400 subjects will be randomized between a treatment group and a control group. Subjects will be followed for a minimum of 5 years after undergoing hip fracture repair surgery.

Fuente oficial

Ver en ClinicalTrials.gov →

Datos obtenidos de la API de ClinicalTrials.gov. Para conocer el estado más reciente, consulte el registro oficial.